Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: DataM Intelligence | PRODUCT CODE: 1560817

Cover Image

PUBLISHER: DataM Intelligence | PRODUCT CODE: 1560817

Global Lithotripter Devices Market - 2024 - 2031

PUBLISHED:
PAGES: 183 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 4350
PDF & Excel (Multiple User License)
USD 4850
PDF & Excel (Enterprise License)
USD 7850

Add to Cart

Report Overview

The Global Lithotripter Devices Market reached US$ 1.15 billion in 2023 and is expected to reach US$ 1.87 billion by 2031 growing with a CAGR of 6.3% during the forecast period 2024-2031.

A lithotripter is a medical device utilized for the treatment of kidney stones and other calculi (stones) within the urinary tract. It operates by generating shock waves that break the stones into smaller fragments, allowing them to be more easily expelled through urination. The primary types of lithotripters include extracorporeal shock wave lithotripsy (ESWL) devices and intracorporeal lithotripsy devices.

ESWL devices produce shock waves outside the body, which are directed at the location of the stones using imaging techniques such as X-ray or ultrasound. The shock waves penetrate the body and fragment the stones without the need for surgical intervention. ESWL is recognized as the most common and least invasive method for treating kidney stones.

Intracorporeal lithotripsy devices are inserted directly into the body to break up stones. They employ various energy sources, including laser, electrohydraulic, mechanical, or ultrasonic energy, to fragment the stones. Intracorporeal lithotripsy is typically used when ESWL is not suitable, such as in cases involving stones located in the ureter or those that resist fragmentation through ESWL.

Market Dynamics: Drivers

Increasing incidence of urolithiasis and technological advancements

The demand for the global lithotripter devices market is driven by multiple factors. One of the primary factors is the increasing incidence of urolithiasis and technological advancements. The rising prevalence of kidney stones and related urolithiasis conditions is a primary driver for the demand for lithotripsy devices. Continuous innovations in lithotripsy technology are significantly enhancing treatment outcomes and driving market growth.

These advancements focus on developing more effective and safer devices, that address both clinical efficacy and patient safety. Innovations such as burst wave lithotripsy (BWL) and high-frequency shock waves represent significant advancements in the treatment of kidney stones, enhancing both the effectiveness of stone fragmentation and the safety of the procedure.

Moreover, key players in the industry product launches and key developments that would propel this market growth. For instance, in May 2024, Dornier MedTech launched UroGPT, the first artificial intelligence tool specifically designed to assist patients dealing with kidney stones. This innovative application aims to enhance patient care by providing reliable, on-demand information and actionable insights related to kidney stone management.

Also, in March 2024, Boston Scientific is set to support kidney stone treatment in South Korea with its Lumenis Pulse 120H Holmium Laser System, which incorporates the advanced MOSES 2.0 technology. This system is designed to enhance the efficiency and effectiveness of lithotripsy procedures, which are critical for managing urolithiasis, or kidney stones.

Restraints

Factors such as the availability of alternative treatment options, and adverse effects associated with lithotripsy devices are expected to hamper the market.

Market Segment Analysis

The global lithotripter devices market is segmented based on type, application, end-user, and region.

The extracorporeal shock wave lithotripsy devices (ESWL) segment accounted for approximately 72% of the global lithotripter devices market share

The extracorporeal shock wave lithotripsy devices (ESWL) segment is expected to hold the largest market share over the forecast period. Extracorporeal Shock Wave Lithotripsy (ESWL) is a non-invasive medical technique primarily utilized for the treatment of kidney stones. This procedure uses shock waves to fragment the stones into smaller pieces, making it easier for them to be passed through the urinary tract. ESWL is preferred due to its effectiveness and the reduced recovery time it offers in comparison to conventional surgical methods.

Moreover, government initiatives & support, financial investments, and key developments would propel this market growth. For instance, in June 2023, King George Hospital, part of Barking, Havering, and Redbridge University Hospitals NHS Trust, faced challenges in reducing the elective surgery backlog in its urology department. To address this, the hospital invested in a new Extracorporeal Shock Wave Lithotripsy (ESWL) machine to treat patients with kidney stones more efficiently.

Similarly, in May 2023, Health Minister Ma. Subramanian inaugurated an Extracorporeal Shock Wave Lithotripsy (ESWL) Treatment Centre at the Government Kilpauk Medical College (KMC) Hospital. The ESWL machine, which was funded by the MOBIS India Foundation through its corporate social responsibility initiatives, costs ₹2.3 crore.

Market Geographical Share

North America accounted for approximately 44.6% of the global lithotripter devices market share

North America region is expected to hold the largest market share over the forecast period owing to the increasing occurrence of kidney stones is a major factor driving the lithotripsy device market in North America. This rising prevalence creates a greater need for effective treatment solutions, such as lithotripsy, which is favored for its non-invasive approach to managing kidney stones.

The shift in patient preference towards minimally invasive and non-invasive procedures is a significant trend in modern healthcare, particularly in the context of lithotripsy for kidney stones. Ongoing advancements in lithotripsy technology, particularly the creation of more efficient and safer devices, are improving treatment results. Innovations like burst wave lithotripsy and high-frequency shock waves enable more accurate targeting of kidney stones, reducing the risk of damage to adjacent tissues.

Moreover, a major number of key players' presence, well-advanced healthcare infrastructure, product launches & approvals, and government initiatives help to drive this market growth. For instance, in March 2024, Calyxo Inc. received FDA approval for its redesigned CVAC (Continuous Vacuum Aspiration Catheter) system, which is specifically designed to collect kidney stone fragments following laser lithotripsy procedures. This innovative device aims to enhance the effectiveness of kidney stone treatments by minimizing the residual stone burden that can lead to complications.

Similarly, in May 2024, Huons Meditech showcased its electromagnetic shock wave lithotripter, the ASADAL-M1, at the American Urological Association (AUA) 2024 Conference held in Texas. This event is one of the most prestigious urological conferences globally, attracting leading urologists and healthcare professionals to discuss innovations and advancements in the field.

Market Segmentation

By Type

Extracorporeal Shock Wave Lithotripsy Devices (ESWL)

Intracorporeal Lithotripsy Devices

Mechanical Lithotripsy

Electrohydraulic Lithotripsy (EHL)

Laser Lithotripsy

Ultrasonic Lithotripsy

By Application

Kidney Stones

Ureteral Stones

Pancreatic Stones

Bile Duct Stones

By End-User

Hospitals

Specialty Clinics

Ambulatory Surgical Centers

By Region

North America

U.S.

Canada

Mexico

Europe

Germany

U.K.

France

Spain

Italy

Rest of Europe

South America

Brazil

Argentina

The rest of South America

Asia-Pacific

China

India

Japan

South Korea

Rest of Asia-Pacific

Middle East and Africa

Market Competitive Landscape

The major global players in the lithotripter devices market include Boston Scientific Corporation, EDAP TMS, Richard Wolf GmbH, Olympus, Cook, Dornier MedTech., DirexGroup, STORZ MEDICAL AG, KARL STORZ, and ELMED Medical Systems among others

Key Developments

In February 2023, Rhein Laser introduced the UroFiber 150Q system, a cutting-edge SuperPulsed thulium fiber laser (TFL) technology designed to enhance treatments for stone lithotripsy and benign prostatic hyperplasia (BPH) enucleation. This system is notable for being the world's first 150W SuperPulsed TFL system, which allows for more effective and efficient procedures in urology.

Why Purchase the Report?

To visualize the global lithotripter devices market segmentation based on type, application, end-user, and region and understand key commercial assets and players.

Identify commercial opportunities by analyzing trends and co-development.

Excel data sheet with numerous data points on the lithotripter devices market in all segments.

PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.

Product mapping is available in excel consisting of key products of all the major players.

The global lithotripter devices market report would provide approximately 62 tables, 52 figures, and 183 pages.

Target Audience 2024

Manufacturers/ Buyers

Industry Investors/Investment Bankers

Research Professionals

Emerging Companies

Product Code: MD68

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Type
  • 3.2. Snippet by Application
  • 3.3. Snippet by End-User
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing Incidence of Urolithiasis and Technological Advancements
    • 4.1.2. Restraints
      • 4.1.2.1. Availability of Alternative Treatment Options
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis

6. By Type

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 6.1.2. Market Attractiveness Index, By Type
  • 6.2. Extracorporeal Shock Wave Lithotripsy Devices (ESWL) *
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Intracorporeal Lithotripsy Devices
    • 6.3.1. Mechanical Lithotripsy
    • 6.3.2. Electrohydraulic Lithotripsy (EHL)
    • 6.3.3. Laser Lithotripsy
    • 6.3.4. Ultrasonic Lithotripsy

7. By Application

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 7.1.2. Market Attractiveness Index, By Application
  • 7.2. Kidney Stones *
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Ureteral Stones
  • 7.4. Pancreatic Stones
  • 7.5. Bile Duct Stones

8. By End-User

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.1.2. Market Attractiveness Index, By End-User
  • 8.2. Hospitals *
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Specialty Clinics
  • 8.4. Ambulatory Surgical Centers

9. By Region

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.2.6.1. U.S.
      • 9.2.6.2. Canada
      • 9.2.6.3. Mexico
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.3.6.1. Germany
      • 9.3.6.2. U.K.
      • 9.3.6.3. France
      • 9.3.6.4. Spain
      • 9.3.6.5. Italy
      • 9.3.6.6. Rest of Europe
  • 9.4. South America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.4.6.1. Brazil
      • 9.4.6.2. Argentina
      • 9.4.6.3. Rest of South America
  • 9.5. Asia-Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.5.6.1. China
      • 9.5.6.2. India
      • 9.5.6.3. Japan
      • 9.5.6.4. South Korea
      • 9.5.6.5. Rest of Asia-Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

10. Competitive Landscape

  • 10.1. Competitive Scenario
  • 10.2. Market Positioning/Share Analysis
  • 10.3. Mergers and Acquisitions Analysis

11. Company Profiles

  • 11.1. Boston Scientific Corporation*
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio and Description
    • 11.1.3. Financial Overview
    • 11.1.4. Key Developments
  • 11.2. EDAP TMS
  • 11.3. Richard Wolf GmbH
  • 11.4. Olympus
  • 11.5. Cook
  • 11.6. Dornier MedTech.
  • 11.7. DirexGroup
  • 11.8. STORZ MEDICAL AG,
  • 11.9. KARL STORZ
  • 11.10. ELMED Medical Systems. (*LIST NOT EXHAUSTIVE)

12. Appendix

  • 12.1. About Us and Services
  • 12.2. Contact Us
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!